The Project
Provide a detailed report on current practice and standards of care within the therapy area. Develop clinical stakeholder map; recommend market access strategy and propose outline plan
Actions undertaken
- Business opportunity determined through analysis of latest disease incidence and prevalence and assessment of unmet need
- Current treatment guidelines assessed with gap analysis undertaken
- Key stakeholders and treatment networks identified
- Customer perspectives collated regarding product profiling and key benefit analysis, through in-depth interviews with leading clinical experts and patient groups.
- Provided connections for expert support to align regulatory process and orphan GB designation with current regulatory strategy
- Recommendations made for initial pricing submission in line with pricing strategy
- Market access recommendations made and scoped out technical expert support for implementation
Results
- Market access, regulatory and communications next steps fully clarified
- Market entry ‘readiness’ in place pending pivotal phase III results
MoorPharm Consulting has given us clarity on how to progress in the UK, and also provided an excellent foundation for potential market entry. Their proactivity, insight and project leadership give us confidence and we will certainly seek their operational support when the time comes to launch
CEO – European Specialist Pharmaceutical company